Kyle Ford
Impact in
-
- Ocular Oncology and Treatments
Papers in
-
- CRISPR and Genetic Engineering 4
- Single-cell and spatial transcriptomics 3
- Protein Degradation and Inhibitors 1
- Oncology 4
- CAR-T cell therapy research 3
- Lung Cancer Research Studies 1
- Co-authors
- Prashant Mali (9 shared papers)Daniella McDonald (2 shared papers)Simone Lubrano (1 shared paper)J. Silvio Gutkind (2 shared papers)Nadia Arang (2 shared papers)Chi‐Ping Day (1 shared paper)Manoela Tiago (1 shared paper)Takami Sato (1 shared paper)
- Journals
- Scientific Reports (2 papers)Biomaterials (1 paper)Clinical Cancer Research (1 paper)Nature Genetics (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Kyle Ford
11 papers receiving 156 citations
Peers
Comparison fields: 5 of 54
- Business and International Management 5
- Ophthalmology 22
- Aging 4
- Immunology and Allergy 13
- Molecular Biology 110
Countries citing papers authored by Kyle Ford
This map shows the geographic impact of Kyle Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Ford more than expected).
Fields of papers citing papers by Kyle Ford
This network shows the impact of papers produced by Kyle Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Ford. The network helps show where Kyle Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 55 | |
| 2 | 2021 | 54 | |
| 3 | 2017 | 15 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 6 | |
| 6 | 2019 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2013 | 0 |
About Kyle Ford
Kyle Ford is a scholar working on Molecular Biology, Oncology, Computational Theory and Mathematics, Aging and Biophysics, having authored 12 papers that have together received 158 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Single-cell and spatial transcriptomics (3 papers), CAR-T cell therapy research (3 papers), Cell Image Analysis Techniques (2 papers), Computational Drug Discovery Methods (2 papers), Genetics, Aging, and Longevity in Model Organisms (2 papers), Lung Cancer Research Studies (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Business and International Management (5 citations), Ophthalmology (22 citations), Aging (4 citations), Immunology and Allergy (13 citations) and Molecular Biology (110 citations). Kyle Ford has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Prashant Mali, Daniella McDonald, Simone Lubrano, J. Silvio Gutkind, Nadia Arang, Chi‐Ping Day, Manoela Tiago, Takami Sato, Jonathan A. Pachter and Glenn Merlino. Their work appears in journals such as Scientific Reports, Biomaterials, Clinical Cancer Research, Nature Genetics and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.